Compare FINW & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINW | OSUR |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.7M | 207.2M |
| IPO Year | 2021 | 2000 |
| Metric | FINW | OSUR |
|---|---|---|
| Price | $14.50 | $4.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 20.8K | ★ 791.9K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.51 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $160.48 | $4.48 |
| Revenue Next Year | $35.27 | $7.76 |
| P/E Ratio | $72.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.82 | $2.08 |
| 52 Week High | $22.49 | $4.33 |
| Indicator | FINW | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 84.27 |
| Support Level | $12.82 | $2.84 |
| Resistance Level | $17.39 | N/A |
| Average True Range (ATR) | 0.49 | 0.20 |
| MACD | 0.20 | 0.14 |
| Stochastic Oscillator | 93.01 | 98.27 |
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.